www.alopexx.com/press_release/alopexx-announced-today-that-sanofi-aventis-exercises-option-to-acquire-exclusive-and-worldwide-rights-to-alopexx-pharmaceuticals-novel-human-monoclonal-antibody-targeting-infectious-diseases

Cambridge, MA , October 27, 2010 – sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has recently elected to exercise its option to acquire an exclusive and ...

constantinecannon.com/2017/12/22/2017-whistleblower-year-nominee-sanofi-aventis

Dec 22, 2017 ... This “Whistleblow er Spotlight” features Sanofi Aventis US, one of our candidates for 2017 Whistleblower of the Year. The US subsidiary of the ...

twitter.com/sanofi?lang=en

The latest Tweets from Sanofi (@sanofi). Sanofi is a global life sciences company , focused on patient's needs. Interactions with this account must comply with the ...

www.genengnews.com/news/sanofi-aventis-inks-539m-deal-to-purchase-fovea

Oct 1, 2009 ... Sanofi-Aventis is purchasing Fovea Pharmaceuticals for €370 million (about $538.72 million), which includes up-front and milestone payments.

ir.ionispharma.com/news-releases/news-release-details/sanofi-aventis-and-regulus-therapeutics-form-major-strategic

Regulus and sanofi-aventis will collaborate on up to four microRNA targets, including Regulus' lead fibrosis program targeting microRNA-21. sanofi-aventis also ...

www.ftc.gov/enforcement/cases-proceedings/041-0031/sanofi-synthelabo-aventis-matter

Nov 2, 2004 ... The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in ...

www.dndi.org/achievements/asaq/partnership-overview-2/sanofi

In the partnership with DNDi on ASAQ development, Sanofi-Aventis (now: Sanofi) contributed resources and expertise in 5 main fields: alt ...

investor.regeneron.com/news-releases/news-release-details/regeneron-initiates-major-global-collaboration-sanofi-aventis

Nov 29, 2007 ... Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies.

www.fcpablog.com/blog/2017/8/18/sanofi-aventis-awarded-38-million-for-blowing-whistle-on-epi.html

Aug 18, 2017 ... Big Pharma Sanofi-Aventis was awarded $38.7 million Thursday as its share of a $465 million False Claims Act settlement by Mylan for ...